
In the September 2021 issue of Aesthetic Plastic Surgery an article on this topic was published entitled ‘Nonsurgical Redefinition of the Chin and Jawline of Younger Adults With a Hyaluronic Acid Filler: Results Evaluated With a Grid System Approach.’ In this paper the authors used a highly cohesive injectable filler (VYC-25L) to augment the chin and jawlines of thirty (30) patients and assessed the outcomes with a standard grid-based approach (horizontal and vertical lines) of their before and after pictures.
The average volume of injectable filler used was around 4mls. (4 syringes) Using the 5-point Global Aesthetic Improvement sale, the vast majority of the patients (97%, 29/30) felt that had significant improvement in the prominence of the lower third of their face. The transient post-injection adverse sequelae were swelling (half the patients) and bruising. (1/5 of the patients) No significant medical complications occurred. (infection, numbness, skin discoloration)
The use of injectable fillers for facial bone augmentations continues to evolve with the use of higher G prime fillers. These increased cohesive fillers provide a better push on the overlying soft tissues which is needed in particular for chin and jawline augmentation. This study adds further support to their effectiveness and safety. While not providing a long-term solution to lower facial augmentation needs, such injectable fillers offer patients an immediate augmentation effect which can fulfill shorter term aesthetic goals.
Dr. Barry Eppley
Indianapolis, Indiana

